Yale/NIDA Proteomics Center Project Investigators




Name

Department

Institution

Website

Project Title

James Bibb Psychiatry
University of Alabama at Birmingham
James A. Bibb, Ph.D. Phosphoproteomic Studies of NMDA Receptor-Cdk5 Interactions
Thomas Biederer Neuroscience Tufts University School of Medicine Thomas Biederer, Ph.D.
Identification and Analysis of Protein Complexes Mediating Synapse Formation
Sreeganga Chandra Neurology Yale University Sreeganga Chandra, Ph.D. Neuronal Substrates Required for Synapse Maintenance
Pietro De Camilli Cell Biology Yale University Pietro De Camilli, M.D. Endocytic Mechanisms and Phosphoinositide Metabolism at Synapses
Lakshmi Devi Pharmacology & Systems Therapeutics Mount Sinai School of Medicine Lakshmi Devi, Ph.D. Identification of Novel Modulators of Opioid Receptor Signaling During Drug Addiction
Elizabeth A. Eipper Neuroscience University of Connecticut Health Center Elizabeth A. Eipper, Ph.D. Effects of Cocaine Treatment on Kalirin Phosphorylation and Function
William N. Green Neurobiology University of Chicago William N. Green, Ph.D. Proteomic Assays of Neuronal Protein Palmitoylation
Paul Greengard Molecular and Cellular Neuroscience Rockefeller University Paul Greengard, Ph.D. The Role of miRNAs in Neuronal Cell Survival and Function
Yasmin Hurd Psychiatry, Neuroscience, Pharmacology, and Systems Therapeutics Mount Sinai School of Medicine Yasmin Hurd, Ph.D. Proteomic Analysis of Neural Epigenetic Mechanisms Underlying Drug-Related Impairments of Synaptic Plasticity
Leonard K. Kaczmarek Pharmacology, Cellular and Molecular Physiology Yale University Leonard K. Kaczmarek, Ph.D. Modulation of Slack and Slick Channels by Protein Phosphorylation
Peter W. Kalivas Neurosciences, Psychiatry, and Behavioral Sciences Medical University South Carolina Peter W. Kalivas, Ph.D.
Quantitative Analysis of S-glutathionylated Proteins After Cocaine Self-administration and Reinstatement
Paul J. Kenny Pharmacology, and Systems Therapeutics Mount Sinai School of Medicine Paul J. Kenny, Ph.D. Role for Transcription Factor TCF7L2 in Nicotine Reinforcement and Schizophrenia
Michael R. Koelle Molecular Biophysics & Biochemistry Yale University
Michael R. Koelle, Ph.D. Proteomic Analysis of Lysine Acetylation of the Neural G Protein Gαo and Its Role in Serotonin Signaling
Paul Lombroso

Child Study Center
Yale University Paul Lombroso, M.D. Involvement of the Tyrosine Phosphatase, STEP, in the Actions of Amphetamine
Ken Mackie Psychological and Brain Sciences Indiana University Ken Mackie, M.D. Phosphorylation Mechanisms of CB1 Cannabinoid Receptor Desensitization
Angus Nairn Psychiatry Yale University Angus Nairn, Ph.D. Regulation of Dopaminergic Signaling by Drugs of Abuse
Eric Nestler Chair, Neuroscience Mount Sinai School of Medicine Eric Nestler, Ph.D., M.D.
Proteomic Analysis of ∆FosB, a Molecular Switch for Addiction
Marina Picciotto Psychiatry, Pharmacology, Neurobiology Yale University Marina Picciotto, Ph.D. Nicotinic Acetylcholine Receptor Interactome
Stephen Strittmatter

Neurobiology,

Neurology

Yale University Stephen Strittmatter, M.D., Ph.D. Proteomic Basis for Chronic Anatomical Plasticity of Synapses
Jane Taylor Psychiatry Yale University Jane Taylor, Ph.D. Proteomic Analysis of Cellular Alterations Associated with Cocaine-Induced Impairments in Incentive-Motivational Processes and Cognitive/Inhibitory Function in Non-Human Primates
Susumu Tomita Cellular and Molecular Physiology
Yale University Susumu Tomita, Ph.D. Identification of Calcium Regulated Phosphorylation Sites In Stargazin-Like TARPs
Mary Torregrossa Psychiatry University of Pittsburgh Mary Torregrossa, Ph.D. Phosphoproteomics of Extinction and Reconsolidation of Drug Cue Memories
Dan Wu Pharmacology Yale University Dan Wu, Ph.D. Lipid and Proteomic Analyses in Wnt Signaling